PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data

Key Takeaways PLSE reported 100% procedural success at six months and 96% at one year in a 150-patient AF cohort.Pulse Biosciences showed short procedures and 1.3% serious adverse events, with 9.8-minute fluoroscopy.PLSE plans pivotal IDE studies in Europe and the U.S., following positive feasibility results for nPulse.Pulse Biosciences (PLSE) recently announced late-breaking data from its first-in-human feasibility study of the nPulse Cardiac Catheter System using Nanosecond Pulsed Field Ablation energy. P ...